Nurse Practitioner Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Jennifer Short

Nurse Practitioner, Family Scott Depot, WV Nurse Practitioner

NPI 1437899622 CMS profile 11373555

300 Corporate Center Drive, Scott Depot, WV 25560

Open in the dashboard

General payments

$9,528

172 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jennifer Short of Scott Depot, WV is reported in the CMS Open Payments database as having received $9,528 across 172 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Nurse Practitioner, Family profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $682 35
2024 General $672 24
2023 General $1,101 48
2022 General $7,073 65

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jennifer Short
  • Nurse Practitioner, Family median
  • Middle half of Nurse Practitioner, Family
  • National median

In program year 2025, general payments to Jennifer Short were reported at $682. Among 107,232 Nurse Practitioner, Family profiles paid that year, the median was $168 and the middle half received between $53 and $521.

Show as a table
Year Jennifer Short Nurse Practitioner, Family median Middle half National median
2019 $0 $39 $18–$91 $163
2020 $0 $32 $17–$76 $114
2021 $0 $124 $35–$379 $132
2022 $7,073 $141 $44–$430 $149
2023 $1,101 $154 $49–$476 $160
2024 $672 $165 $51–$504 $164
2025 $682 $168 $53–$521 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Edwards Lifesciences Corporation $3,885 38 payments
  2. Boston Scientific Corporation $2,167 20 payments
  3. Medtronic, Inc. $1,692 13 payments
  4. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $584 39 payments
  5. Biogen, Inc. $272 18 payments
  6. Pfizer Inc. $174 5 payments
  7. Boehringer Ingelheim Pharmaceuticals, Inc. $152 9 payments
  8. ConvaTec Inc. $125 1 payment
  9. SK Life Science, Inc. $82 5 payments
  10. AstraZeneca Pharmaceuticals LP $71 5 payments
  11. Other $323 19 payments

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Travel and Lodging $5,231 18 payments
  2. Food and Beverage $4,165 151 payments
  3. Education $132 3 payments
Products named General payments · program years 2022–2025
  1. EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) $1,990 22 payments
  2. WATCHMAN Access System $1,774 11 payments
  3. COREVALVE EVOLUT R $1,669 12 payments
  4. LifeVest $584 39 payments
  5. SAPIEN 3 Ultra RESILIA $272 8 payments
  6. WATCHMAN FLX $269 8 payments
  7. VYNDAQEL $174 5 payments
  8. Edwards SAPIEN 3 Ultra Transcatheter Heart Valve $152 3 payments
  9. JARDIANCE $152 9 payments
  10. VUMERITY $144 9 payments
  11. Other $883 41 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

70

Median for Nurse Practitioner: 389

Drug cost

$7,226

Median for Nurse Practitioner: $21,885

Branded share of claims

100%

Median for Nurse Practitioner: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 13 $6,615
Clopidogrel Clopidogrel Bisulfate Brand 57 $611

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 4 billing codes

Paid by Medicare

$1,514

Medicare's payments for the services billed

Medicare patients

24

Average age 79

Services billed

25

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Atrial fibrillation 75%
Arthritis 75%
Diabetes 67%
Chronic kidney disease 67%
Heart failure 54%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

3 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
KENGREAL
  • CHIESI USA, INC. $31
$31 — —
VYNDAQEL
  • PFIZER INC. $17
$17 — —
WAINUA
  • AstraZeneca Pharmaceuticals LP $14
$14 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

172 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Family in West Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record